Accuray

ARAY

0.14200.70% ( -0.0010 )

Closed: Oct 20, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.34, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 67/173, the industry Median -0.93.

-0.345xP/E

Stock price$0.14Earnings per share$-0.41

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.92x	141.71%	$12.67B
GKOSUSGlaukos	-54.40x	75.37%	$10.23B
TFXUSTeleflex	-5.39x	118.39%	$5.56B
IRTCUSIRhythm	-269.08x	71.47%	$3.75B
PLSEUSPulse Biosciences	-45.29x	26.85%	$3.63B
ASSTUSStrive	-3.44x	63.23%	$3.36B
AXGNUSAxogen	-63.26x	16.18%	$2.12B
BFLYUSButterfly Network	-26.01x	31.45%	$1.95B
NVCRUSNovocure	-12.31x	1.23%	$1.83B
ATECUSAlphatec	-15.25x	41.67%	$1.68B
KMTSUSKestra Medical Tech	-11.06x	0.94%	$1.66B
DRTSUSAlpha Tau Medical	-13.06x	--	$1.21B
ENOVUSEnovis	-1.08x	100.97%	$1.19B
TNDMUSTandem Diabetes	-18.15x	77.60%	$1.15B
AORTUSArtivion	-352.80x	266.67%	$1.13B
PRCTUSPROCEPT BioRobotics	-9.82x	3.47%	$1.08B
CBLLUSCeribell	-16.10x	35.15%	$1.06B
IARTUSIntegra LifeSciences	-143.25x	108.85%	$1.04B
QDELUSQuidelOrtho	-0.93x	75.33%	$974.46M
BBNXUSBeta Bionics	-12.80x	11.45%	$933.87M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.